You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
聯邦制藥(03933.HK):控股股東擬配售最多6400萬股
格隆匯 09-19 08:26

格隆匯9月19日丨聯邦制藥(03933.HK)發佈公吿,公司接獲公司控股股東Heren Far East Limited(“Heren”)(一間以家族成員蔡海山先生、蔡紹哲女士及寧桂珍女士(統稱“蔡氏家族”)為受益人所成立的家族信託間接全資擁有的公司)通知,2023年9月18日,Heren已與一名配售代理訂立配售協議,內容有關待配售協議的條件獲達成後,向承配人配售Heren持有的最多6400萬股公司股份,配售價為每股配售股份7.33港元。配售股份於本公吿日期佔公司已發行股本約3.52%。

配售事項完成後,蔡氏家族及其家族信託將繼續持有約48.92%公司已發行股本(假設自本公吿日期起直至配售事項完成止,公司已發行股本概無變動)。待配售協議的條件獲達成後,配售事項預計將於2023年9月21日完成。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account